GO:0005840 ribosome: Components, Assembly and Research

The ribosome (GO:0005840) is an intracellular organelle, approximately 200 Å in diameter, composed of RNA and protein, that serves as the site of protein biosynthesis through translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA, and both the ribosome and its subunits are characterized by their sedimentation coefficients expressed in Svedberg units. The prokaryotic ribosome (70S) comprises a large 50S subunit and a small 30S subunit, whereas the eukaryotic ribosome (80S) comprises a large 60S subunit and a small 40S subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and the peptidyl site (P site), and ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins. Ribosome research matters because translation is the final step in gene expression and is tightly coupled to cell growth, proliferation, and stress responses. Eukaryotic ribosome assembly is a complex, multistep process that requires the coordinated action of hundreds of assembly factors, ribosomal proteins, and small nucleolar RNAs. Defects in ribosome assembly or function can impair translation and trigger quality-control pathways that influence development and disease. Beyond its canonical role, the ribosome is increasingly recognized as a regulatory hub. Ribosome heterogeneity and specialization allow selective translation of specific mRNAs in different tissues and developmental contexts. In protozoan parasites, specialized ribosomes support stage-specific translation and adaptation to host environments. Ribosome stoichiometry, the relative abundance of ribosomal proteins and rRNA, further shapes translational output and cellular physiology. These findings position the ribosome as both a fundamental machine and a dynamic regulatory platform.

GO:0005840 (ribosome) describes an intracellular organelle, about 200 Å in diameter, that consists of RNA and protein and is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It is built from two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). The prokaryotic ribosome (70S) comprises a large 50S subunit and a small 30S subunit, while the eukaryotic ribosome (80S) comprises a large 60S subunit and a small 40S subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and the peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.

The ribosome is essential for translating the genetic code into functional proteins, making it central to virtually every cellular process. Because ribosome assembly and function are tightly linked to cell growth and proliferation, defects in ribosome biogenesis or regulation can have profound consequences for development and disease. Ribosome heterogeneity and specialization further expand the regulatory capacity of translation, allowing cells to respond to developmental cues and environmental stress. Understanding ribosome biology therefore provides mechanistic insight into cancer, ribosomopathies, and infectious disease, and offers opportunities for therapeutic intervention.

The following genes encode ribosomal proteins, assembly factors, and regulatory components that are central to ribosome biology and are commonly studied using CRISPR-based models.

Ribosome biogenesis and function are regulated at multiple levels. The mTOR pathway promotes ribosome production by activating ribosomal protein S6 kinases and driving rRNA transcription. Ribosome stress activates the p53 tumor suppressor pathway, which can induce cell cycle arrest or apoptosis when ribosome assembly is impaired. Ribosome quality-control pathways monitor translation and trigger mRNA decay or ribosome repair under stress conditions. Ribosome heterogeneity and specialization further modulate translation in a cell-type-specific manner.

Ribosomopathies are a group of human disorders caused by mutations in ribosomal proteins or ribosome assembly factors. Diamond-Blackfan anemia, for example, is associated with mutations in RPS19, RPL5, RPS24, and other ribosomal protein genes. These disorders often present with tissue-specific defects, such as bone marrow failure, despite the ubiquitous requirement for ribosomes. Studies using CRISPR models have helped define how specific ribosomal protein mutations impair ribosome assembly and trigger stress responses.

Deregulated ribosome biogenesis is a hallmark of many cancers and is linked to metastasis and therapeutic resistance. Oncogenes such as MYC drive ribosome production to support rapid cell growth. Ribosome heterogeneity and specialized translation can promote tumor adaptation and survival under stress. Targeting ribosome biogenesis or specific ribosomal proteins is an active area of cancer therapeutic research.

Protozoan parasites rely on specialized ribosomes to support stage-specific translation and adaptation to host environments. Differences between parasite and host ribosomes make them attractive targets for antiparasitic drugs. Understanding ribosome specialization in these organisms can inform the development of selective inhibitors.

Ribo-seq measures ribosome occupancy on mRNA transcripts at nucleotide resolution, providing a snapshot of translation. It is used to study how ribosome heterogeneity and specialized ribosomes select specific mRNA subsets. Ribo-seq can also reveal changes in translation efficiency upon knockout or overexpression of ribosome-related genes.

RNA-seq quantifies mRNA abundance and can identify changes in ribosomal protein gene expression. It is often combined with Ribo-seq to distinguish transcriptional from translational regulation. Transcriptomic profiling of ribosomopathy models helps define disease mechanisms.

Proteomics measures the abundance and composition of ribosomal proteins and assembly factors. It can detect changes in ribosome stoichiometry and post-translational modifications. Mass spectrometry is also used to identify interacting partners of ribosomal proteins.

Cryo-electron microscopy and other structural approaches reveal the architecture of ribosomal subunits and assembly intermediates. Fluorescence imaging can track ribosome localization and dynamics in cells. These methods complement biochemical and genetic studies of ribosome function.

Researchers studying ribosome-related genes often need to determine whether a candidate gene is causally involved in translation, ribosome assembly, or disease. EDITGENE provides CRISPR-based cell models and screening services to enable rigorous functional studies of GO:0005840 (ribosome) and its associated genes.

GO:0005840 (ribosome) defines the essential intracellular organelle responsible for translating mRNA into protein. Its assembly, regulation, and heterogeneity are critical for cellular growth, development, and stress responses. Dysregulation of ribosome function is implicated in cancer, ribosomopathies, and parasite biology, making it a key area of biomedical research. CRISPR-based models and advanced profiling methods provide powerful tools to dissect ribosome biology and identify therapeutic targets.